secwatch.observer — SEC 8-K summary
======================================

Issuer:     QHSLab, Inc. (USAQ)
CIK:        0000856984
Form:       8-K
Filed at:   2024-03-28T23:59:59+00:00
Accession:  0001493152-24-011611
Event type: earnings
Sentiment:  positive
Materiality: 0.65
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

QHSLab 2023 revenue up 13% to $1.41M; net loss halved to $(240K)
----------------------------------------------------------------

- Revenue of $1,408,995, up from $1,243,186 in 2022, driven by allergy kits and digital medicine subscriptions.
- Gross margin improved to 56.3% from 49.8%; gross profit $793,607.
- Net operating loss reduced to $(240,158) from $(560,539); sales & marketing down to $488,537.
- New EHR partnership connects 160,000 medical professionals; evidence-based PHQ-9/GAD-7 improvements shown.
- R&D spending increased slightly to $214,008 for proprietary platform enhancements.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/856984/000149315224011611/0001493152-24-011611-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/856984/000149315224011611/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-011611

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer